WebApr 15, 2024 · The stock, however, is off -83.80% from where it was a year ago. Additionally, there is a loss of -2.06% for Cumberland Pharmaceuticals Inc. (CPIX) in last trading while the stock has seen an overall depriciation of -26.73%% over the past year. The PE ratio stands at 11.39 for Ironwood Pharmaceuticals Inc., compared to 70.08 for AstraZeneca PLC. WebNov 4, 2024 · Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported financial results for third quarter 2024. “We remain hi
Ironwood Pharmaceuticals Competitors and Similar Companies
WebConnect Pharmaceuticals Llc is located at 621 E State St, EAGLE 83616, United States. You can call them via phone number 2082442091. Directionus.com. Connect Pharmaceuticals … Webopportunities that are aligned with Ironwood’s mission. Our compensation, benefits and employee development opportunities are designed to attract and retain the high - ly skilled talent we rely on to drive our vision forward. In 2024 and 2024, Ironwood was named to Top Workplaces USA by Energage. As of December 31, 2024, we had 219 employees. how to say giverny
Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD) Stock Could Be …
WebApr 13, 2024 · Ironwood Pharmaceuticals. Inc. (US) Edusa Pharmaceuticals (US) Tioga Pharmaceuticals. Inc. (US) Pharmos Corporation (US) Salix Pharmaceuticals. Inc. (US) Abbott Laboratories (US) Lexicon Pharmaceuticals (US) Dalian Xindie Chitin Co. Ltd. (China) Sucampo Pharmaceuticals. Inc. (US) 产品种类细分: 类型 1. 类型 2. 类型 3. 下游应用 ... WebApr 11, 2024 · finance.yahoo.com - February 10 at 10:29 AM. Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call. finance.yahoo.com - February 2 at 6:17 PM. Ironwood Pharmaceuticals (NASDAQ:IRWD) shareholders are up 3.7% this past week, but still in the red over the last five years. WebApr 10, 2024 · Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation under the LINZESS … north greenhills basketball court